Recombinant activated Factor VII for prevention and treatment of intraventricular haemorrhage in neonates

This review has been withdrawn.

The reason for withdrawal and previous versions are archived and accessible within the withdrawn record in the Cochrane Library.

Published:

10 March 2021

Authors:

Malhotra A, Veldman A

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Malhotra A, Veldman A. Recombinant activated Factor VII for prevention and treatment of intraventricular haemorrhage in neonates (Protocol). Cochrane Database of Systematic Reviews 2021, Issue 3. Art. No.: CD009032. DOI: 10.1002/14651858.CD009032.pub2.